Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – In patients with peptic ulcers, eradication of Helicobacter pylori seemed to double the risk of new-onset reflux – but only in cohort study…
NEW YORK (Reuters Health) – Although inhaled corticosteroids (ICS) can help prevent exacerbations of chronic obstructive pulmonary disease (COPD), an analysis of randomized trials suggests that the benefits…
NEW YORK (Reuters Health) – Long-term treatment with clofazimine or nitroimidazoles may help control Crohn’s disease, according to the authors of a systematic review and meta-analysis. Several bacteria…
NEW YORK (Reuters Health) – In patients with schizophrenia, clozapine does not seem to increase the risk of cardiovascular death relative to risperidone, despite known differences in cardiometabolic…
NEW YORK (Reuters Health) – Whether clopidogrel is abruptly stopped or slowly tapered, there is no evidence of a rebound in platelet activity, German researchers report. They point…
NEW YORK (Reuters Health) – Stimulant medications show greater efficacy than nonstimulants for treating attention-deficit/hyperactivity disorder (ADHD) in adults, according to a new meta-analysis. Study authors Dr. Stephen…
NEW YORK (Reuters Health) – For hepatocellular carcinomas (HCC) larger than 2 cm, radiofrequency ablation (RFA) is the best ablative therapy, a meta-analysis shows – but for smaller…
NEW YORK (Reuters Health) – Adding trastuzumab (Herceptin) to standard chemotherapy can significantly improve event-free survival in women with HER2-positive locally advanced or inflammatory breast cancer, according to…
NEW YORK (Reuters Health) – L-carnitine supplements can improve liver function, liver histology and other manifestations of nonalcoholic steatohepatitis (NASH), Italian researchers say. “L-carnitine supplementation induces regression of…
NEW YORK (Reuters Health) – Tight glycemic control may increase the risks of mortality and cardiovascular disease, new research suggests. Moderate control, with glycosylated hemoglobin A1c (HbA1c) levels…
